🌍 New Quality Improvement Programme Alert! 🌍 We're excited to introduce our latest Quality Improvement Programme, designed to empower primary care professionals with crucial insights into the impact of COVID-19 on heart and circulatory disease complications. 💙 Why It Matters: As we continue to navigate post-pandemic healthcare, understanding the long-term effects of COVID-19 on cardiovascular health is vital. This programme will enable primary care to deepen their knowledge, helping to provide better, more informed care for patients impacted by these complex conditions. 📈 Programme includes: -Impact of COVID-19 -Background of the problem -Patient identification and activation -Interventions, guidelines and treatment options We hope you enjoy this programme.
Primary Care Cardiovascular Society (PCCS)’s Post
More Relevant Posts
-
During the Asia-Pacific Cardiovascular Disease Alliance Lunch Dialogue titled "Cardiovascular Care Resilience in the Asia-Pacific" at the 2024 Annual Conclave, Dr Raja Ezman Raja Shariff reminded the audience that heart care can be improved. Dr. Raja’s quote is a stark reminder that a multidisciplinary approach in CVD care breaks down silos between specialists, fostering communication and collaboration, and therefore cannot be overlooked. This ensures patients receive a more comprehensive and coordinated treatment plan, ultimately improving their chances of a better quality of life. You can watch the full recording of the session through the link in the comments section below. Stay tuned for more insights from the Annual Conclave. #CardiovascularHealth #HeartHealth #CardiacRehabilitation #MultiDisciplinaryCare #PatientCare #ImproveHeartCare #HealthcareInnovation #MedicationManagement
To view or add a comment, sign in
-
🚨 New Article Published: The Transformation of CVD Policy in the UK 🚨 We're excited to announce the publication of our latest article on the evolving landscape of cardiovascular disease (CVD) policy in the UK. 🇬🇧💙 The article discusses the key findings of the Darzi Report and highlights the urgent need for preventative care, increased investment in CVD services, and improved access to diagnostic tools. It also covers the recent campaign by the British Heart Foundation for a national CVD plan, aiming to prevent up to 11,000 early deaths per year by 2035. 🫀📊 👉 Learn more here: https://lnkd.in/egGgCiFQ #EUSHDcoalition #earlydetection #awareness #healthcare
To view or add a comment, sign in
-
Cardiovascular disease (#CVD) remains the leading cause of death worldwide, as highlighted by the World Health Organization (WHO). According to the American Heart Association every 40 seconds, someone in the U.S. will have a heart attack. This places immense pressure on healthcare systems, making advanced technologies and innovative treatment methods more important than ever to improve patient outcomes while minimizing risks. At VentriLabs, we are proud to be contributing to the development of tomorrow's life-saving medical equipment. Our innovative pump technology is developed with the patient in mind, aiming to enhance the safety and effectiveness of circulatory support systems to ultimately improve the treatment of patients in need of external circulatory support. #HealthcareInnovation #MedTech #CVD #ECMO #CPB
To view or add a comment, sign in
-
Effective care coordination and transition planning are essential to improving patient outcomes and eliminating unnecessary healthcare expenditures. This is especially true in the management of chronic kidney disease and end-stage renal disease. The complex, long-term nature of kidney disease requires consistent communication and collaboration among various providers. We cover this topic and strategies to improve care coordination and transitions in the latest Healthmap Solutions White Paper, “Care Coordination and Care Transitions In Value-based Kidney Disease Management.” Download it now from the link below: <<https://lnkd.in/dxYK-zCG>>
To view or add a comment, sign in
-
🌍 Today, on World Patient Safety Day, the World Orphan Drug Congress joins the global call to prioritise safety in healthcare, particularly for patients facing rare diseases. This year, the focus is on enhancing diagnostic safety to ensure every patient receives timely and accurate diagnoses. Misdiagnosis or delayed diagnosis can greatly impact treatment outcomes for rare disease patients, making this mission even more critical. Let’s come together to: 1️⃣ Empower patients to be proactive in their diagnosis. 2️⃣ Support healthcare professionals in maintaining excellence in diagnostic practices. 3️⃣ Leverage innovation and technology to improve diagnostic accuracy. Together, we can create safer, more reliable healthcare systems 💙. For more details on how to get involved, visit the WHO’s World Patient Safety Day 2024 page. #WorldPatientSafetyDay #PatientSafety #OrphanDrugs #RareDisease #DiagnosticExcellence #WODC #WorldOrphanDrugCongress
To view or add a comment, sign in
-
Diagnosing acute cardiovascular events quickly can improve patient outcomes, but disparities in healthcare and varying symptoms lead to inequities in diagnosis. This American Heart Month, view our resources on diagnostic excellence for acute cardiovascular events: https://ow.ly/9lTl50QzMGu #HeartMonth #CardiovascularEvents #Diagnosis
To view or add a comment, sign in
-
In Crohn’s disease (CD), evolving management goals emphasize a treat-to-target approach. The STRIDE II consensus, developed by healthcare providers (HCPs), aims for endoscopic healing and clinical remission. However, survey data reveal that HCPs and patients may differ in perspectives on symptoms like bowel urgency and fatigue. Addressing these patient experiences is essential for comprehensive CD management. HCPs can learn more here: https://e.lilly/3W94Oa0
To view or add a comment, sign in
-
Today is World Patient Safety Day🌐, and it serves as an important reminder of the collective responsibility we have across the life sciences industry. Whether you're working in pharma, biotech, healthcare, or research, patient safety must always be at the heart of what we do. In the orphan drug and rare disease space, ensuring accurate diagnoses and safe treatment protocols is particularly crucial. Many patients face long journeys towards diagnosis, making safety in healthcare delivery even more vital. By fostering collaboration, promoting innovation, and encouraging best practices, we can make strides in improving patient outcomes. View the WHO recommended best practices below! #WorldPatientSafetyDay #LifeSciences #PatientFirst #OrphanDrugs #PatientSafety #HealthcareInnovation
🌍 Today, on World Patient Safety Day, the World Orphan Drug Congress joins the global call to prioritise safety in healthcare, particularly for patients facing rare diseases. This year, the focus is on enhancing diagnostic safety to ensure every patient receives timely and accurate diagnoses. Misdiagnosis or delayed diagnosis can greatly impact treatment outcomes for rare disease patients, making this mission even more critical. Let’s come together to: 1️⃣ Empower patients to be proactive in their diagnosis. 2️⃣ Support healthcare professionals in maintaining excellence in diagnostic practices. 3️⃣ Leverage innovation and technology to improve diagnostic accuracy. Together, we can create safer, more reliable healthcare systems 💙. For more details on how to get involved, visit the WHO’s World Patient Safety Day 2024 page. #WorldPatientSafetyDay #PatientSafety #OrphanDrugs #RareDisease #DiagnosticExcellence #WODC #WorldOrphanDrugCongress
To view or add a comment, sign in
-
The treatment paradigm for early relapsed/refractory #MultipleMyeloma is constantly evolving. Stay up to date by watching an expert presentation from Rakesh Popat, UCL Hospitals NHS Foundation Trust, London, UK, on the latest developments in early relapsed disease. 🎥 👉 https://loom.ly/C5g5ol8 #mmsm #myeloma #ESHMM2024
To view or add a comment, sign in
-
November is COPD Awareness Month – a month dedicated to raising awareness of Chronic Obstructive Pulmonary Disease and the critical role healthcare professionals play in its management. Early detection and intervention are key to improving outcomes, and strategies like airway clearance therapy can significantly enhance the quality of life for those living with COPD. Let’s come together to increase awareness, share knowledge, and provide comprehensive support to those living with COPD. By working collaboratively, we can make a meaningful impact on patient outcomes. Looking for resources to help support your patients? https://lnkd.in/gVQcWedR
To view or add a comment, sign in
920 followers